Skip to main content

Case Comprehensive Cancer Center

gerson-stan-new.jpeg
Inhibiting WRD5 Shows Promise for Treating Glioblastoma
In a paper published in Genes & Development, investigators identified the protein WRD5 as a promising way to turn off cancer “stemness” at a molecular level, clearing the way for treatment like chemotherapy to kill glioblastoma cells. Cancer stem cells, like regular stem cells, can inherently…
HIV-virus
Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
Case Western Reserve University has completed an exclusive license agreement with Atlanta-based RORA Biologics Inc. (RORA-Bio) for intellectual property to develop new therapies to treat HIV and certain kinds of cancer. The agreement gives RORA-Bio exclusive international rights to T-cell memory…
WP-option
Columbia University's Gary Schwartz named Case Comprehensive Cancer Center's new director
A Columbia University oncologist renowned for his translational research, mentoring and leadership will become director of the Case Comprehensive Cancer Center (Case CCC) this spring. Gary Schwartz, chief of the Hematology & Oncology Division at Columbia University Irving Medical Center…
quad-aerial-feat
Researchers Markowitz, Tyler elected fellows for 2022 class of National Academy of Inventors
Colon cancer pioneer and neural engineering innovator join nearly 20 others from Case Western Reserve in last decade on list Case Western Reserve University researchers Sanford "Sandy" Markowitz and Dustin Tyler have been elected fellows of The National Academy of Inventors (NAI). The honor…
breast-cancer-awareness-feat
Busting myths about breast cancer
In October, pink ribbons become a common sight as organizations promote breast cancer awareness. The goal of these efforts is to encourage those at risk of developing the disease to get mammograms in hopes of catching potential diagnoses early, when treatment is most effective. But despite…
nate-berger-feat
CWRU Medicine Professor Nathan Berger earns school's Lifetime Achievement Award
Nathan Berger has produced decades of biomedical research into cancer development and its associated risk factors. He is a nationally renowned authority on hematology and oncology and founding member of the Case Comprehensive Cancer Center, a consortium between Case Western Reserve, University…
cancer-cells
Merck Foundation awards Case Comprehensive Cancer Center 5-year, $2M grant to advance equitable cancer care in Northeast Ohio
The Case Comprehensive Cancer Center (Case CCC) recently announced it received a $2 million grant through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the Merck Foundation (the Foundation) and designed to make cancer care more equitable in the United States by…
sickle-cell-feat
5 things to know about… sickle cell disease
September is National Sickle Cell Awareness Month, which aims to bring attention to advancing research, care practices, treatments and possible cures for people with sickle cell disease. Umut Gurkan To better understand this blood disorder, The Daily sat down with Umut Gurkan, a professor in the…
esophagus
Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate
Researchers say pathway is linked to tumor development Research led by Case Western Reserve University has identified a promising path to developing therapies to treat esophageal tumors—a form of cancer that not only is among the most deadly, but also has been occurring at increasing rates over…
stan-gerson-feat
Medicine’s Stanton Gerson writes about breakthroughs in cancer
Stanton Gerson, dean of the School of Medicine, shared his view on why 2022 is a breakthrough year in our battle against cancer in an op-ed published by Crain’s Cleveland Business. Titled “Personal View: A breakthrough year in the war on cancer,” Gerson’s piece described the role the Case…